Magnetic pulses to the brain could help depressed patients think more clearly
NCT ID NCT07161492
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a non-invasive brain stimulation technique called rTMS can improve cognitive flexibility—the ability to adapt thinking—in people with major depression. 105 participants will receive either active stimulation to two brain areas, active stimulation to one area, or sham (fake) stimulation, over 10 days. Researchers will measure changes in thinking skills, mood, and brain activity using tests and MRI scans.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- repetitive transcranial magnetic stimulation (rTMS)
- What this could lead to
- If it works, this could offer a new, non-invasive way to improve thinking and mental flexibility in people with depression, beyond what antidepressants alone can do.
- What could go wrong
- This is an early-stage trial with only 105 participants, so results may not apply to everyone. The treatment is short (10 days) and effects may not last long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 105 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Meet DSM-5 criteria for major depressive episode confirmed by the Structured Clinical Interview for DSM-5 Disorders (SCID-5), with no prior manic or hypomanic episodes; diagnosed as major depressive disorder without psychotic features by two attending psychiatrists. First episode or recurrent, currently in a depressive episode (HAMD\_17≥17). Age 18 to 45 years, all sexes and genders. Han Chinese, right-handed. Junior high school education or above, no color blindness, able to understand and provide informed consent, and complete assessments and tests. Willing to participate voluntarily and sign written informed consent. Exclusion Criteria: Meet DSM-5 diagnostic criteria for any psychiatric disorder other than major depressive disorder. Received non-pharmacological treatments within the past 6 months, such as electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS), or systematic psychotherapy (≥ 10 sessions). Prior treatment with CCRT. Received antipsychotics or other medications affecting cognitive function within the past month, or cholinergic agents (e.g., donepezil, galantamine) within 14 days, memantine within 20 days, or other racetam drugs (e.g., piracetam) within 2 days prior to randomization. Organic brain disorders or severe physical illnesses (e.g., thyroid disease, lupus erythematosus, diabetes, liver/kidney/lung impairment, infection, major trauma). History of traumatic brain injury with loss of consciousness or other conditions that may interfere with this study. History of alcohol or substance abuse or dependence. Severe suicidal ideation or suicide attempt . Currently receiving hormonal therapy. Pregnancy, lactation, possibility of pregnancy, or planned pregnancy. History of epilepsy or family history of epilepsy. Implanted metal materials in the body (e.g., pacemaker, dental implants, metal intrauterine device). Any other factors that, in the investigator's opinion, place the participant at potential risk or interfere with the study participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive impairment are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Xiangya Second Hospital of Central South University
Changsha, Hunan, 410011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can virtual reality make memory therapy more powerful?
- Can a tuned brain implant sharpen thinking in Parkinson's?
- Gut bacteria meets brain health: can a daily probiotic drink sharpen memory in older adults?
- Muscle relaxant showdown: which drug keeps drivers steadier?
- Can a memory drug and precision radiation save thinking during brain cancer treatment?
- A blocked neck artery may steal your memory. can a procedure bring it back?